Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEPHSTROM: ORBCEL-M for Diabetic Kidney Disease
NCT02585622Phase 2Terminated
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Dec 2017
- Primary completion
- Nov 2022
- Modality
- Stem Cell Therapies
- Countries
- 3
01
Overview
A Phase 2 trial of ORBCEL-M in diabetic kidney disease (DKD), sponsored by Mario Negri Institute for Pharmacological Research. Started Dec 2017; status: terminated.
02
Drugs
ORBCEL-M
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT02585622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02585622.